Addressing Health Inequities in Clinical Diagnostics (R43/R44 Clinical Trials Not Allowed)
ID: 352685Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Small Businesses

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/352685

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-24-158.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "Addressing Health Inequities in Clinical Diagnostics" (R43/R44), aimed at encouraging Small Business Concerns (SBCs) to develop improved clinical diagnostics that address health disparities. Applicants are required to identify specific diagnostic disparities that perpetuate health inequities and propose innovative solutions to enhance clinical laboratory assays and point-of-care devices, ensuring they adequately represent diverse patient populations. This initiative is crucial for promoting health equity and improving health outcomes for underserved groups disproportionately affected by inequitable healthcare practices. Funding is available through SBIR grants, with budgets of up to $306,872 for Phase I and $2,045,816 for Phase II projects, and applications must be submitted by January 5, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-24-158-Full-Announcement.html
    PAR-24-158.html
    The Department of Health and Human Services is offering a funding opportunity titled "Addressing Health Inequities in Clinical Diagnostics" (R43/R44), aimed at encouraging Small Business Concerns (SBCs) to develop improved clinical diagnostics that address health disparities. This initiative, led by the National Institutes of Health and several participating institutes, focuses on enhancing clinical laboratory assays and point-of-care devices that inadequately represent diverse patient populations, leading to health inequities. Applicants are tasked with identifying diagnostic disparities, proposing solutions, and ensuring accessibility to underserved populations. Funding is available through SBIR grants, with budgets reaching up to $306,872 for Phase I and $2,045,816 for Phase II projects, without including clinical trials. The application process requires adherence to strict guidelines, with multiple deadlines for submissions. Review criteria will assess the significance of the project, investigator qualifications, innovation, approach, and the potential to promote health equity among health disparity populations. Overall, this funding aims to catalyze systemic changes in diagnostics to improve health outcomes for diverse groups disproportionately affected by inequitable healthcare practices.
    Similar Opportunities
    Addressing Health Inequities in Clinical Diagnostics (R41/R42 Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the "Addressing Health Inequities in Clinical Diagnostics" grant, aimed at encouraging small businesses to develop innovative clinical diagnostic tools that address health disparities. Applicants are required to identify specific issues within existing clinical diagnostics that contribute to health inequities, particularly affecting underrepresented populations, and propose viable solutions to enhance equitable access to quality healthcare. This funding opportunity, which falls under the R41/R42 grant mechanism, does not support clinical trials and emphasizes the importance of stakeholder engagement from health disparity populations. Interested applicants can find more information and submit their proposals by the ongoing deadlines, with the final submission date set for January 5, 2027. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov or visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-24-157.html.
    Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities," aimed at supporting U.S. small businesses in developing innovative technologies, products, or services that address health disparities among minority populations. Eligible applicants are encouraged to propose solutions that enhance healthcare delivery, promote health-seeking behaviors, and overcome barriers in minority health, with funding available through the Small Business Innovation Research (SBIR) program for both Phase I and II grants. This initiative underscores the government's commitment to advancing health equity and leveraging small business innovation to tackle significant healthcare challenges faced by underserved communities. Applications are due by December 10, 2026, and interested parties can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the Small Business Technology Transfer (STTR) program, aimed at developing technologies to improve minority health and eliminate health disparities. Eligible applicants, specifically United States small business concerns (SBCs), are invited to submit grant applications for the R41/R42 program, which may include clinical trials, focusing on innovative solutions that are effective, affordable, and culturally acceptable for underserved populations. This initiative emphasizes the importance of addressing health inequities through technology, including disease self-management tools and mobile health solutions, with applications due by December 9, 2026. For further details, applicants can refer to the full announcement at NIH Grants or contact NIH Grants Information at grantsinfo@nih.gov.
    Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional)" aimed at developing medical technologies that address health disparities among underserved populations in the U.S. This initiative encourages grant applications focused on creating effective, affordable, culturally acceptable, and accessible medical solutions, including devices, imaging systems, and telehealth innovations, while emphasizing the importance of formal collaborations with healthcare organizations serving these populations. The NIH plans to allocate approximately $2.4 million for this initiative, with an award ceiling of $500,000 per project, and expects to fund 3-4 awards over a project duration of up to four years. Interested applicants must submit their proposals by May 2, 2025, and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    SBIR Solutions to Enable Population Genomic Screening (R43/R44 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "SBIR Solutions to Enable Population Genomic Screening," aimed at soliciting Small Business Innovation Research (SBIR) grant applications from U.S. small businesses. The objective of this initiative is to develop innovative solutions that facilitate population genomic screening for common, actionable genomic conditions within primary care settings, addressing significant barriers such as logistical challenges, provider education, and follow-up procedures. This program is crucial for enhancing the readiness of primary care providers to manage genomic screening, particularly for conditions like hereditary breast cancer and Lynch syndrome. Grants of up to $400,000 are available for Phase I applications, with Phase II grants potentially reaching $2.15 million. Interested applicants should note that the submission window opens on November 1, 2024, with a deadline for applications set for December 2, 2024. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Investigator-Initiated Research in Genomics and Health Equity" (RFA-HG-23-017), aimed at promoting health equity through innovative genomic research. This initiative encourages applicants to propose research that enhances the understanding and application of genomics across diverse U.S. populations, with a particular focus on engaging underrepresented groups and incorporating a Plan for Enhancing Diverse Perspectives (PEDP). The NIH plans to commit significant funds, with a maximum budget of $500,000 in direct costs per year for projects lasting four to five years, and applications are due by July 8, 2025. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries and are encouraged to review the full announcement at NIH Grants.
    Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)" aimed at supporting small-scale research projects that enhance health equity through genomic research. The initiative seeks to develop innovative approaches and metrics to ensure the equitable application of genomics in improving health outcomes for U.S. populations, particularly focusing on historically underrepresented groups in biomedical research. Eligible applicants include a wide range of organizations, such as higher education institutions, nonprofit organizations, and state governments, with funding available up to $200,000 annually for a maximum of two years. Interested parties should submit their applications by July 8, 2025, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage for more details at https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-23-018.html.
    Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a federal grant opportunity titled "Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities," aimed at supporting intervention research to improve health outcomes among minority populations affected by health disparities. The initiative seeks projects that investigate the influence of structural racism and discrimination on health determinants, promote multidisciplinary collaboration, and utilize diverse data sources for comprehensive analysis. With a funding ceiling of $500,000, the application deadline is set for January 7, 2026, and interested applicants can find more information and submission guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Effectiveness of School-Based Health Centers to Advance Health Equity (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Effectiveness of School-Based Health Centers to Advance Health Equity," aimed at investigating the effectiveness of school-based health centers (SBHCs) in addressing health disparities among underserved youth. This initiative seeks to support multidisciplinary research that assesses how SBHCs can detect, manage, and prevent chronic illnesses in school-aged children, particularly those from low socioeconomic backgrounds, while also exploring the integration of SBHC services with educational outcomes and care coordination for at-risk youth. Eligible applicants include a diverse range of organizations, such as higher education institutions, community-based organizations, and tribal colleges, with applications due by January 8, 2025. For further details, interested parties can contact the NIH OER Webmaster at grantsinfo@nih.gov or visit the funding announcement at http://grants.nih.gov/grants/guide/pa-files/PAR-21-287.html.
    Advancing Health Equity through Interventions to Prevent and Address Housing Instability (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Health Equity through Interventions to Prevent and Address Housing Instability," aimed at supporting research that addresses housing instability as a social determinant of health. The initiative seeks applications that develop, test, and evaluate interventions impacting health outcomes related to housing challenges, such as homelessness and rent burdens, with an emphasis on inclusivity through a Plan for Enhancing Diverse Perspectives (PEDP). This funding opportunity reflects a commitment to mitigating health disparities linked to housing issues, with a total funding amount of $3 million available for 4-6 awards, each capped at $500,000 for a duration of up to five years. Interested applicants must submit their proposals by December 13, 2024, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.